Is Hidradenitis Suppurativa Spreadable? Here’s What You Should Know

Introduction

Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that causes painful lumps, abscesses, and sinus tracts, primarily in areas with sweat glands like the armpits, groin, and buttocks (Sabin et al., 2019). One common misconception about HS is whether it is spreadable or contagious. While the symptoms may resemble infections, HS is not spread from person to person (Alikhan et al., 2009). Understanding its nature, causes, and management can help dispel myths and promote effective treatment.

At EliteAyurveda, we provide a holistic approach to managing HS, focusing on its root causes and overall well-being.

How Hormones Influence Psoriasis

How Hormones Influence Psoriasis

Is HS Contagious?

The simple answer is no, Hidradenitis Suppurativa is not contagious (Ingram et al., 2016). It cannot be spread through:

  1. Physical contact with an affected person.
  2. Sharing personal items like towels or clothing.
  3. Sexual activity or other intimate interactions.

HS is not caused by bacteria or viruses, making it fundamentally different from contagious skin conditions like impetigo or fungal infections (Sabin et al., 2019).

What Causes Hidradenitis Suppurativa?

HS is an autoimmune condition, meaning the body’s immune system mistakenly attacks its own tissues (Gulliver et al., 2012). The exact cause is unknown, but it is linked to the following factors:

1. Hair Follicle Blockage

  • In HS, hair follicles become clogged, leading to inflammation and abscess formation (Jemec & Heidenheim, 1996).

2. Overactive Immune Response

  • The immune system’s excessive response causes chronic inflammation and tissue damage (Giamarellos-Bourboulis et al., 2016).

3. Genetic Predisposition

  • HS often runs in families, suggesting a hereditary component (Fimmel & Zouboulis, 2020).

4. Hormonal Fluctuations

  • Hormones play a significant role, as HS often worsens during puberty, menstrual cycles, and pregnancy (van der Zee & Prens, 2011).

5. Lifestyle and Environmental Factors

  • Smoking, obesity, and stress are known to aggravate HS symptoms (Egeberg et al., 2017).

Common Misconceptions About HS

1. “HS is an Infection.”

While the lesions and abscesses of HS can become secondarily infected, the condition itself is not caused by infection. The inflammation originates from blocked hair follicles and immune system dysfunction (Sabin et al., 2019).

2. “You Can Catch HS from Someone Else.”

Since HS is not caused by a pathogen, it cannot be transmitted through contact or shared items (Alikhan et al., 2009).

3. “Poor Hygiene Causes HS.”

HS is not related to cleanliness. It is a medical condition with underlying genetic, hormonal, and immune factors (Gulliver et al., 2012).

Why the Misconception About Contagion Exists

The visible symptoms of HS—such as abscesses, pus, and scarring—can resemble contagious skin conditions. This leads to stigma and misinformation, often causing emotional distress for those living with HS (Machado et al., 2019). Educating patients and the public is essential to combating this stigma.

How HS Manifests

1. Early Stages

  • Small, tender lumps resembling boils (Ingram et al., 2016).
  • These may heal temporarily but often recur in the same area.

2. Progression

  • Abscesses deepen and form sinus tracts (tunnels under the skin) (Sabin et al., 2019).
  • Scarring and pigmentation changes occur over time.

3. Chronic Stage

  • Severe, persistent inflammation and interconnected sinus tracts.
  • This can lead to restricted movement and emotional distress (Gulliver et al., 2012).

Ayurvedic Perspective on Hidradenitis Suppurativa

In Ayurveda, HS is viewed as an imbalance in the Pitta (fire) and Kapha (water and earth) doshas, combined with toxin buildup (Ama) in the body (Lad, 2002). These imbalances manifest as chronic inflammation, blockages, and abscess formation.

Key Ayurvedic Insights

  • Pitta Aggravation: Causes heat and inflammation, leading to redness and swelling (Frawley, 2000).
  • Kapha Imbalance: Contributes to blockages and sluggish circulation, causing recurrent lumps (Pole, 2013).
  • Ama (Toxins): Poor digestion and metabolic inefficiencies lead to toxin accumulation, exacerbating symptoms (Sharma et al., 2007).

Holistic Management of HS Through Ayurveda

At EliteAyurveda, we focus on addressing the root causes of HS with personalized treatment plans.

1. Detoxification (Shodhana)

  • Purpose: Remove toxins from the body to reduce inflammation and prevent recurrence (Sharma et al., 2007).
  • Methods: Specialized external Ayurvedic therapies and herbal formulations tailored to individual needs (Pole, 2013).

2. Personalized Herbal Medications

  • Goal: Balance Pitta and Kapha doshas, strengthen immunity, and support skin healing (Lad, 2002).

3. Dietary Adjustments

  • Foods to Favor: Cooling, anti-inflammatory foods like leafy greens, cucumbers, and coconut water (Frawley, 2000).
  • Foods to Avoid: Spicy, oily, and processed foods that aggravate inflammation (Pole, 2013).

4. Lifestyle Modifications

  • Stress Management: Incorporate yoga, meditation, and pranayama to reduce stress (Sharma et al., 2007).
  • Hydration and Hygiene: Regular hydration and gentle skincare to support healing (Lad, 2002).

5. Regular Follow-Ups

  • Monitoring progress and adjusting treatment as needed for long-term management.

Case Study: A Patient’s Journey with HS

Patient Profile:

  • Name: Meera (Name Changed)
  • Age: 29
  • Symptoms: Recurrent abscesses in the groin and underarms for 5 years, with scarring and pain.
  • Previous Diagnosis: Misdiagnosed as a bacterial infection and treated with antibiotics, which offered no relief.

Treatment Plan:

  1. Detoxification: Weekly Ayurvedic therapies to cleanse the lymphatic system and reduce inflammation (Sharma et al., 2007).
  2. Herbal Medications: Customized formulations to balance Pitta and Kapha (Lad, 2002).
  3. Dietary Guidance: Anti-inflammatory and Pitta-pacifying diet (Frawley, 2000).
  4. Stress Management: Daily yoga and mindfulness practices to reduce triggers (Sharma et al., 2007).

Outcome:

  • 8 Weeks: Reduced frequency and severity of flare-ups.
  • 6 Months: No new abscesses, with noticeable improvement in scarring and overall skin texture.

Key Takeaways

  1. HS is Not Contagious: It is a chronic inflammatory condition with no infectious origin (Alikhan et al., 2009).
  2. Holistic Care is Essential: Addressing root causes through Ayurveda ensures sustainable relief (Sharma et al., 2007).
  3. Educate and Empower: Understanding HS helps dispel myths and reduce stigma (Machado et al., 2019).

Conclusion

Hidradenitis Suppurativa is a complex condition that requires a comprehensive approach for effective management. While it is not contagious, its impact on physical and emotional health can be profound. At EliteAyurveda, we focus on restoring balance to the body through personalized, Ayurvedic care, helping patients achieve long-term relief and improved quality of life.

Take control of your HS journey today.

📞 Contact us at +91 8884722246

🌐 Visit our website: www.eliteayurveda.com

Related-

Know More About Ayurveda Treatment For Psoriasis

GET IN TOUCH

Schedule a Visit

Contact us

References

1.Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol. 2007;25(6):535–546. doi: 10.1016/j.clindermatol.2007.08.007. [DOI] [PubMed] [Google Scholar]

2.Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun. 2007;8(1):1–12. doi: 10.1038/sj.gene.6364351. [DOI] [PubMed] [Google Scholar]

3.Batycka-Baran A, Maj J, Wolf R, Szepietowski JC. The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis. J Immunol Res. 2014 doi: 10.1155/2014/628289. [DOI] [PMC free article] [PubMed] [Google Scholar]

4.Schafer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology. 2006;212(4):327–337. doi: 10.1159/000092283. [DOI] [PubMed] [Google Scholar]

5.Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3(2):121–128. doi: 10.2174/1568010043343958. [DOI] [PubMed] [Google Scholar]

6.Christophers E. Psoriasis–epidemiology and clinical spectrum. Clin Exp Dermatol. 2001;26(4):314–320. doi: 10.1046/j.1365-2230.2001.00832.x. [DOI] [PubMed] [Google Scholar]

7.Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–224. doi: 10.1016/j.jaad.2008.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]

8.Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34(3):J314–J321. doi: 10.1016/j.jaut.2009.12.001. [DOI] [PubMed] [Google Scholar]

9.Xhaja A, Shkodrani E, Frangaj S, Kuneshka L, Vasili E. An epidemiological study on trigger factors and quality of life in psoriatic patients. Mater Sociomed. 2014;26(3):168–171. doi: 10.5455/msm.2014.26.168-171. [DOI] [PMC free article] [PubMed] [Google Scholar]

10.Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol. 2000;17(3):174–178. doi: 10.1046/j.1525-1470.2000.01746.x. [DOI] [PubMed] [Google Scholar]

11.Hébert HL, Bowes J, Smith RL, Flynn E, Parslew R, Alsharqi A, et al. Identification of loci associated with late-onset psoriasis using dense genotyping of immune-related regions. Br J Dermatol. 2015;172(4):933–939. doi: 10.1111/bjd.13340. [DOI] [PubMed] [Google Scholar]

12.Lønnberg AS, Skov L, Duffy DL, Skytthe A, Kyvik KO, Pedersen OB, et al. Genetic Factors Explain Variation in the Age at Onset of Psoriasis: A Population-based Twin Study. Acta Derm Venereol. 2016;96(1):35–38. doi: 10.2340/00015555-2171. [DOI] [PubMed] [Google Scholar]

13.Islam MT, Paul HK, Zakaria SM, Islam MM, Shafiquzzaman M. Epidemiological determinants of psoriasis. Mymensingh Med J. 2011;20(1):9–15. [PubMed] [Google Scholar]

14.Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK, editors. Dermatology. Vol. 14. Berlin: Springer Verlag; 1991. Erythematous and erythematosquamous skin diseases; pp. 417–435. [Google Scholar]

15.Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Karkkainen P. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990;300(6727):780–783. doi: 10.1136/bmj.300.6727.780. [DOI] [PMC free article] [PubMed] [Google Scholar]

16.Farkas A, Kemény L. Psoriasis and alcohol: is cutaneous ethanol one of the missing links? Br J Dermatol. 2010;162(4):711–716. doi: 10.1111/j.1365-2133.2009.09595.x. [DOI] [PubMed] [Google Scholar]

17.Milavec-Puretić V, Mance M, Ceović R, Lipozenčić J. Drug induced psoriasis. Acta Dermatovenerol Croat. 2011;19(1):39–42. [PubMed] [Google Scholar]

18.Rongioletti F, Fiorucci C, Parodi A. Psoriasis induced or aggravated by drugs. J Rheumatol Suppl. 2009;83:59–61. doi: 10.3899/jrheum.090227. [DOI] [PubMed] [Google Scholar]

19.Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol. 2010;3(1):32–38. [PMC free article] [PubMed] [Google Scholar]

20.Keerthi S, Rangaraj M, Karthikeyan K. Telmisartan aggravates pustular psoriasis. J Pharmacol Pharmacother. 2015;6(2):107–109. doi: 10.4103/0976-500X.155492. [DOI] [PMC free article] [PubMed] [Google Scholar]

21.Wu W, Debbaneh M, Moslehi H, Koo J, Liao W. Tonsillectomy as a treatment for psoriasis: a review. J Dermatolog Treat. 2014;25(6):482–486. doi: 10.3109/09546634.2013.848258. [DOI] [PMC free article] [PubMed] [Google Scholar]

22.Weigl BA. The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int J Dermatol. 2000;39(9):678–688. doi: 10.1046/j.1365-4362.2000.00800.x. [DOI] [PubMed] [Google Scholar]

23.Halawani MR. Dermatological manifestations of hepatitis C virus infection in Saudi Arabia. Saudi Med J. 2014;35(6):531–537. [PubMed] [Google Scholar]

24.Imafuku S, Naito R, Nakayama J. Possible association of hepatitis C virus infection with late-onset psoriasis: a hospital-based observational study. J Dermatol. 2013;40(10):813–818. doi: 10.1111/1346-8138.12240. [DOI] [PubMed] [Google Scholar]

25.Ito T, Furukawa F. Psoriasis guttate acuta triggered by varicella zoster virus infection. Eur J Dermatol. 2000;10(3):226–227. [PubMed] [Google Scholar]

26.Wiemers S, Krutmann J, Kapp A, Schöpf E. Postherpetic erythema exsudativum multiforme with concomitant exacerbation of psoriasis vulgaris. Hautarzt. 1990;41(9):506–508. [PubMed] [Google Scholar]

27.Bhalerao J, Bowcock AM. The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet. 1998;7(10):1537–1545. doi: 10.1093/hmg/7.10.1537. [DOI] [PubMed] [Google Scholar]

Related Posts:

RELATED ARTICLESMORE FROM AUTHOR